Literature DB >> 15649705

RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.

Yoshio Bando1, Taiichi Katayama, Manabu Taniguchi, Tomohiko Ishibashi, Noriyuki Matsuo, Satoshi Ogawa, Masaya Tohyama.   

Abstract

Parkinson's disease is characterized by selective loss of dopaminergic neurons in the substantia nigra. However, its associated cell death mechanism remains unknown. 1-Methyl-4-phenil-pyridinium (MPP+) and 6-hydroxydopamine (6-OHDA) cause dopaminergic neuronal cell death. Both are widely used to model PD. We investigated the role of a vesicle-transport-related protein, RA410/Sly1, in SH-SY5Y cells to clarify the mechanism of cellular adaptation to MPP+ and 6-OHDA-induced stress. Antisense RA410/Sly1 transformants treated with these toxins displayed reduced viability in comparison with viability of wild-type or RA410/Sly1 sense transformants. Electron microscopy analysis indicated that the ER in MPP+-treated antisense RA410/Sly1 transformants was rapidly disrupted in comparison to wild-type or sense RNA transformants. Cell death induced by MPP+ and 6-OHDA was suppressed in RA410/Sly1 sense transformants through suppression of caspase-2, -3 and -9 activation. These results suggest that RA410/Sly1 plays an important cytoprotective role in MPP+ and 6-OHDA-induced cellular perturbation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649705     DOI: 10.1016/j.nbd.2004.09.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

1.  Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?

Authors:  Polyxeni Stamati; Vasileios Siokas; Athina-Maria Aloizou; Emmanouil Karampinis; Stylianos Arseniou; Valerii N Rakitskii; Aristidis Tsatsakis; Demetrios A Spandidos; Illana Gozes; Panayiotis D Mitsias; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  J Mol Neurosci       Date:  2019-07-02       Impact factor: 3.444

2.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

3.  A knockout of the caspase 2 gene produces increased resistance of the nigrostriatal dopaminergic pathway to MPTP-induced toxicity.

Authors:  Meenakshi Tiwari; Brian Herman; William W Morgan
Journal:  Exp Neurol       Date:  2011-03-16       Impact factor: 5.330

Review 4.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed.

Authors:  Alfredo Iacoangeli; Isabella Fogh; Sashika Selvackadunco; Simon D Topp; Aleksey Shatunov; Wouter van Rheenen; Ahmad Al-Khleifat; Sarah Opie-Martin; Antonia Ratti; Andrea Calvo; Philip Van Damme; Wim Robberecht; Adriano Chio; Richard J Dobson; Orla Hardiman; Christopher E Shaw; Leonard H van den Berg; Peter M Andersen; Bradley N Smith; Vincenzo Silani; Jan H Veldink; Gerome Breen; Claire Troakes; Ammar Al-Chalabi; Ashley R Jones
Journal:  Brain Commun       Date:  2021-10-07

Review 6.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

7.  Lack of an association between SCFD1 rs10139154 polymorphism and amyotrophic lateral sclerosis.

Authors:  Vasileios Siokas; Athina-Maria Aloizou; Ioannis Liampas; Christos Bakirtzis; Grigorios Nasios; Konstantinos Paterakis; Markos Sgantzos; Dimitrios P Bogdanos; Demetrios A Spandidos; Aristidis Tsatsakis; Panayiotis D Mitsias; Efthimios Dardiotis
Journal:  Mol Med Rep       Date:  2022-03-02       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.